SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma - Quaterly Results

17 May 2024 Evaluate
A minor change in the total revenue was seen in the March 2024 quarter. The total revenue for the quarter stood at Rs. 1638.91 millions against Rs. 1573.10 millions during year ago period.The Profit  for the quarter ended March 2024 of  Rs. 153.59  millions  grew by 59.61% from Rs. 96.23 millions.Operating Profit saw a handsome growth to 220.46 millions from 152.70 millions in the quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1638.91 1573.10 4.18 6470.04 5274.86 22.66 6470.04 5274.86 22.66
Other Income 28.22 10.37 172.13 120.98 61.15 97.84 120.98 61.15 97.84
PBIDT 220.46 152.70 44.37 872.47 573.90 52.02 872.47 573.90 52.02
Interest 1.01 0.23 339.13 3.54 2.18 62.39 3.54 2.18 62.39
PBDT 219.45 152.47 43.93 868.93 571.72 51.99 868.93 571.72 51.99
Depreciation 22.27 24.07 -7.48 85.84 97.00 -11.51 85.84 97.00 -11.51
PBT 197.18 128.40 53.57 783.09 474.72 64.96 783.09 474.72 64.96
TAX 43.59 32.17 35.50 182.52 112.91 61.65 182.52 112.91 61.65
Deferred Tax -2.24 -5.93 -62.23 3.59 -8.29 -143.31 3.59 -8.29 -143.31
PAT 153.59 96.23 59.61 600.57 361.81 65.99 600.57 361.81 65.99
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 13.45 9.71 38.58 13.48 10.88 23.94 13.48 10.88 23.94

Anuh Pharma Share Price

82.80 0.08 (0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×